Enodia Therapeutics Acquires Kezar Life Sciences-Preclinical Assets
Enodia Therapeutics acquired Kezar Life Sciences-Preclinical Assets for $127.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Enodia Therapeutics
- Acquired Company
- Kezar Life Sciences-Preclinical Assets
- Price
- $127.0M
- Acquisition Type
- Acquisition
- Announced
- March 12, 2026
Canonical: https://fsome.com/acquisitions/enodia-therapeutics-acquires-kezar-life-sciences-preclinical-assets-17200429 · For the full deal terms, timeline, and press references, please enable JavaScript.